KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Shares Issued (2016 - 2025)

Abbott Laboratories' Shares Issued history spans 17 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 80.0% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $396.0 million, up 50.0%, while the annual FY2025 figure was $396.0 million, 50.0% up from the prior year.
  • Shares Issued for Q4 2025 was $5.0 million at Abbott Laboratories, down from $69.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $287.0 million in Q1 2025 and bottomed at $5.0 million in Q4 2025.
  • The 5-year median for Shares Issued is $56.5 million (2022), against an average of $62.4 million.
  • The largest annual shift saw Shares Issued soared 412.5% in 2021 before it tumbled 80.0% in 2025.
  • A 5-year view of Shares Issued shows it stood at $82.0 million in 2021, then crashed by 50.0% to $41.0 million in 2022, then decreased by 17.07% to $34.0 million in 2023, then dropped by 26.47% to $25.0 million in 2024, then crashed by 80.0% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Shares Issued are $5.0 million (Q4 2025), $69.0 million (Q3 2025), and $35.0 million (Q2 2025).